FindTrial
Sign In

New Treatments for Mouth Cancer: Using Nanotechnology and Iron Targeting in Clinical Trials

Risk stratification and advancing precision therapy strategies for Oral Squamous Cell Carcinoma (OSCC) through the integration of Nanotechnology-enhanced Nutritional interventions with comprehensive Randomized controlled Trials: Exploring the Therapeutic potential of targeting Iron-Responsive Elements (IREs) and their binding proteins.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075945
Enrollment
100
Registered
2024-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K137- Other and unspecified lesions of oral mucosa

Interventions

Intervention1: Nano-Iron: The supplement, containing iron nanoparticles and essential nutrients, aims to disrupt tumor iron metabolism, inhibiting cancer cell growth. Participants will receive a daily

Sponsors

Indian Council of Medical Research DHRDepartment of Health Research New Delhi India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Non habit OSCC patients and healthy individuals

Exclusion criteria

Exclusion criteria: patient without habits

Design outcomes

Primary

MeasureTime frame
Overall Survival (OS), Progression-Free Survival (PFS) will be assessed at regular time intervals at baseline, 3rd month, 6 th month, 9th month and 12 th monthTimepoint: Overall Survival (OS), Progression-Free Survival (PFS) will be assessed at regular time intervals at baseline, 3rd month, 6 th month, 9th month and 12 th month—

Secondary

MeasureTime frame
Response Rate (RR), Quality of Life (QoL),Biomarker Response, Safety and Tolerability Timepoint: 3 years—

Countries

India

Contacts

Public ContactHema Shree K

Saveetha Dental College, SIMATS

hemashree9111990@gmail.com9994975670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026